Sha Chen

935 total citations · 1 hit paper
29 papers, 450 citations indexed

About

Sha Chen is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Sha Chen has authored 29 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Hepatology, 16 papers in Surgery and 14 papers in Epidemiology. Recurrent topics in Sha Chen's work include Liver Diseases and Immunity (15 papers), Pediatric Hepatobiliary Diseases and Treatments (13 papers) and Liver Disease Diagnosis and Treatment (10 papers). Sha Chen is often cited by papers focused on Liver Diseases and Immunity (15 papers), Pediatric Hepatobiliary Diseases and Treatments (13 papers) and Liver Disease Diagnosis and Treatment (10 papers). Sha Chen collaborates with scholars based in China, United States and Netherlands. Sha Chen's co-authors include Jidong Jia, Yuanyuan Kong, Ruben Coronel, Coert J. Zuurbier, Markus W. Hollmann, Nina C. Weber, Tingting Lv, Hong You, Min� Li and Dong Zhang and has published in prestigious journals such as Hypertension, The American Journal of Surgical Pathology and Medicine.

In The Last Decade

Sha Chen

24 papers receiving 447 citations

Hit Papers

Direct cardiac effects of SGLT2 inhibitors 2022 2026 2023 2024 2022 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sha Chen China 11 246 195 187 94 67 29 450
Jen‐Jung Pan United States 15 229 0.9× 167 0.9× 332 1.8× 108 1.1× 104 1.6× 36 584
Nancy E. Aguilar-Olivos Mexico 14 232 0.9× 202 1.0× 301 1.6× 62 0.7× 41 0.6× 24 523
Mona Lalehzari United States 3 303 1.2× 104 0.5× 388 2.1× 79 0.8× 34 0.5× 5 475
Taeang Arai Japan 13 201 0.8× 49 0.3× 276 1.5× 94 1.0× 47 0.7× 45 413
Rajani Sharma United States 11 180 0.7× 82 0.4× 286 1.5× 63 0.7× 27 0.4× 27 381
Tsuyoshi Todo United States 11 499 2.0× 198 1.0× 703 3.8× 204 2.2× 75 1.1× 32 942
Saira Khaderi United States 13 323 1.3× 119 0.6× 300 1.6× 37 0.4× 37 0.6× 27 494
Han Ah Lee South Korea 11 360 1.5× 55 0.3× 438 2.3× 97 1.0× 41 0.6× 46 563
Soichiro Shibata Japan 15 383 1.6× 130 0.7× 430 2.3× 38 0.4× 104 1.6× 26 590
Hideaki Taniguchi Japan 11 105 0.4× 104 0.5× 228 1.2× 111 1.2× 15 0.2× 29 382

Countries citing papers authored by Sha Chen

Since Specialization
Citations

This map shows the geographic impact of Sha Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sha Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sha Chen more than expected).

Fields of papers citing papers by Sha Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sha Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sha Chen. The network helps show where Sha Chen may publish in the future.

Co-authorship network of co-authors of Sha Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Sha Chen. A scholar is included among the top collaborators of Sha Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sha Chen. Sha Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chen, Sha, et al.. (2025). The Impact of Exercise during Pregnancy on Maternal and Offspring Outcomes in Gestational Diabetes Mellitus. Biocell. 49(2). 181–198. 1 indexed citations
3.
Bi, Wang, Xin Xu, Wenjie Liang, et al.. (2025). 7-Hydroxylathyrol defeats geminivirus through targeting C4 and activating host defense. Pesticide Biochemistry and Physiology. 212. 106454–106454.
5.
Lv, Tingting, Shuxiang Li, Sha Chen, et al.. (2024). Clinicopathologic Features of a Rare and Underrecognized Variant of Early-stage Primary Biliary Cholangitis With Ductopenia. The American Journal of Surgical Pathology. 49(3). 265–272. 1 indexed citations
6.
You, Hong, Weijia Duan, Shuxiang Li, et al.. (2023). Guidelines on the Diagnosis and Management of Primary Biliary Cholangitis (2021). Journal of Clinical and Translational Hepatology. 0(0). 0–0. 13 indexed citations
7.
Chen, Sha, Ting Lv, Shan Shan, et al.. (2023). Concomitant gallstone disease was not associated with long‐term outcomes in ursodeoxycholic acid‐treated patients with primary biliary cholangitis. Journal of Digestive Diseases. 24(6-7). 419–426. 1 indexed citations
8.
Chen, Sha, Cees A. Schumacher, Shirley C.M. van Amersfoorth, et al.. (2023). Protease XIV abolishes NHE inhibition by empagliflozin in cardiac cells. Frontiers in Physiology. 14. 1179131–1179131. 6 indexed citations
9.
10.
Kong, Yuanyuan, Tingting Lv, Min� Li, et al.. (2022). Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease. Hepatology International. 16(5). 1052–1063. 4 indexed citations
11.
Chen, Sha, Mengqi Li, Weijia Duan, et al.. (2022). Concomitant extrahepatic autoimmune diseases do not compromise the long-term outcomes of primary biliary cholangitis. Hepatobiliary & pancreatic diseases international. 21(6). 577–582. 4 indexed citations
12.
Chen, Sha, Ruben Coronel, Markus W. Hollmann, Nina C. Weber, & Coert J. Zuurbier. (2022). Direct cardiac effects of SGLT2 inhibitors. Cardiovascular Diabetology. 21(1). 45–45. 111 indexed citations breakdown →
13.
Chen, Sha, Tingting Lv, Guangyong Sun, et al.. (2022). Reciprocal alterations in circulating and hepatic gamma–delta T cells in patients with primary biliary cholangitis. Hepatology International. 16(1). 195–206. 7 indexed citations
14.
Duan, Weijia, Sha Chen, Shuxiang Li, et al.. (2022). The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti‐mitochondrial antibodies but without baseline PBC. Hepatology Communications. 6(11). 3112–3119. 9 indexed citations
15.
Yang, Qingling, Sha Chen, Zhigang Han, et al.. (2021). Increasing the HIV testing among MSM through HIV test result exchange mechanism: study protocol for a cluster randomized controlled trial. BMC Infectious Diseases. 21(1). 764–764. 10 indexed citations
16.
Chen, Sha, Qingling Yang, Juan He, et al.. (2021). Association between relationship characteristics and willingness to use PrEP among same-sex male couples: a cross-sectional actor-partner analysis in Guangzhou, China. International Journal of STD & AIDS. 32(3). 228–238. 3 indexed citations
17.
Duan, Weijia, Sha Chen, Shanshan Wu, et al.. (2019). Epidemiology and clinical course of primary biliary cholangitis in the Asia–Pacific region: a systematic review and meta-analysis. Hepatology International. 13(6). 788–799. 46 indexed citations
18.
Chen, Sha, Weijia Duan, Min� Li, et al.. (2018). Prognosis of 732 ursodeoxycholic acid‐treated patients with primary biliary cholangitis: A single center follow‐up study from China. Journal of Gastroenterology and Hepatology. 34(7). 1236–1241. 18 indexed citations
19.
Chen, Sha, Weijia Duan, Hong You, & Jidong Jia. (2017). A brief review on prognostic models of primary biliary cholangitis. Hepatology International. 11(5). 412–418. 12 indexed citations
20.
Tang, Siping, et al.. (2010). Carboxy and diphosphate ester hydrolysis promoted by di- or tri-nuclear zinc(II) complexes based on β-cyclodextrin. Journal of Molecular Catalysis A Chemical. 335(1-2). 222–227. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026